Additional investigation revealed altered DNA methylation levels in prostate tumors compared with normal prostates for all m6A regulators except VIRMA and EIF3C, the latter one of which was completely devoid of CpG methylation (Figure 1(f) and Supplementary Excel S1). This evidence concerns the gene EIF3C and prostate neoplasm.